News

October 19, 2018

FDA Approves Talzenna to Treat BRCA-mutated Metastatic Breast Cancer

News

The U.S. Food and Drug Administration (FDA) has approved Pfizer’s Talzenna (talazoparib) for the treatment of HER2-negative advanced breast cancer in adult patients with inherited BRCA mutations. The FDA also stated that patients’ eligibility ... Read more

October 17, 2018

‘Where’s My Mammogram?’ Campaign Encourages Women to Keep Track of Breast Images

News

Having earlier breast images for comparison greatly improve breast cancer diagnosis and patient outcomes, but many women in the U.S. either don’t know they have a legal right to ... Read more

October 15, 2018

First Patient Dosed in Phase 1/2 Trial of FLX475 in Breast, Other Advanced Cancers

News

The first patient has been dosed in a Phase 1/2 trial evaluating FLX Bio’s investigational therapy, FLX475, alone and in combination with the PD-1 inhibitor Keytruda (pembrolizumab), as a therapy for ... Read more

October 12, 2018

Mammography Screening Does Not Reduce Breast Cancer Mortality, Study Suggests

News

While fewer women die from breast cancer now compared to a decade ago, the decline is no longer associated with mammography screening, but with improved treatment and healthcare, a ... Read more

October 10, 2018

Fluorescent Tracer Can Improve Detection of Breast Tumor Margins During Surgery

News

A tumor-specific fluorescent tracer improved the detection of breast tumor margins during surgery and may help surgeons remove cancer cells that would otherwise be missed, according to the first ... Read more

October 8, 2018

Sales of Limited-edition Crocs to Support Susan G. Komen Breast Cancer Organization

News

In time for National Breast Cancer Awareness Month, Crocs is supporting the efforts of the world’s largest breast cancer organization, Susan G. Komen, through a new limited edition of its ... Read more

October 3, 2018October 3, 2018

Potential Effects of Thousands of Mutations in BRCA1 Gene Analyzed by Researchers

News

Researchers have analyzed the effects of nearly 4,000 mutations deliberately induced into the BRCA1 gene, one of the genes that increases the likelihood of developing breast cancer and ovarian ... Read more

October 1, 2018

Many Women Being Told of Breast Cancer in Phone Chat with Doctor, Study Finds

News

For more than a decade now, women were more likely to learn they had breast cancer in a telephone conversation with a doctor rather than an office visit, research from the ... Read more

September 28, 2018

CrownBio Acquires Patient-derived Breast Cancer Mouse Models from University of Utah

News

CrownBio has established an agreement with the University of Utah to acquire and commercialize the university’s unique collection of patient-derived mouse models of breast cancer. The models were developed ... Read more

September 24, 2018

First Patient Dosed in Phase 1b Trial Testing Cirmtuzumab Add-on in HER2-negative Breast Cancer Patients

News

A pilot Phase 1 trial evaluating Oncternal Therapeutic’s investigational therapy cirmtuzumab as an add-on to standard chemotherapy for patients with advanced, HER2-negative breast cancer who cannot receive surgery has started ... Read more

Pin It on Pinterest